Mail & Guardian
Mail & Guardian
ciplalatest news & developments
CAB-LA, a long-acting HIV prevention shot is currently being trailed in 3 200 women across Sub-Saharan Africa. (Yolanda Mdzeke, Bhekisisa)
ANTI HIV INJECTION

Anti-HIV injection to be made in SA

CAB-LA will be made at Indian drug company Cipla’s Benoni and Durban plants, but a starting date for production has not yet been announced

  • Zano Kunene
10 min read
The high cost of drugs is putting them out of patients’ reach
CANCER

Generic cancer drug – access not guaranteed

A generic version of a key cancer drug is now available in South Africa, but at a significantly higher cost than it is available internationally.

  • Mara Kardas-Nelson
6 min read
CIPLA

Indian drug firms use SA as launch pad into Africa

India’s pharmaceutical industry has rolled out a strong local presence in South Africa, cornering a large share of the market.

  • Joshua Howat Berger
3 min read